Insider Trading activities at Talphera, Inc. (TLPH)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Talphera, Inc. (TLPH) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Talphera, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1427925.

Total stock buying since 2014: $1,356,487.
Total stock sales since 2014: $7,327,776.
Total stock option exercises since 2014: $152,240.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at *Talphera, Inc.* (*TLPH*).
	Insider Buying		Insider Sales		Option Exercises
Year	Shares	Value	Shares	Value	Shares	Value
2026	220,364	$178,935	0	$0	0	$0
2024	32,955	$30,342	155	$118	0	$0
2023	20,000	$15,220	16,956	$19,235	0	$0
2022	46,400	$10,347	0	$0	0	$0
2020	107,547	$138,936	0	$0	0	$0
2019	92,988	$218,703	0	$0	0	$0
2018	127,610	$369,085	40,520	$199,123	0	$0
2017	72,000	$178,978	898,988	$2,153,751	37,500	$45,000
2016	25,206	$80,521	609,350	$2,294,466	0	$0
2015	75,400	$125,120	578,300	$2,661,083	54,000	$107,240
2014	1,000	$10,300	0	$0	0	$0

Table 2. Monthly summary of insider trading at *Talphera, Inc.* (*TLPH*).
Trading Period	Insider Buying		Insider Sales		Option Exercises
year-month	Shares	Value	Shares	Value	Shares	Value
2026-02	220,364	$178,935	0	$0	0	$0
2024-12	5,000	$3,200	155	$118	0	$0
2024-11	5,000	$3,650	0	$0	0	$0
2024-08	7,260	$7,601	0	$0	0	$0
2024-06	15,695	$15,891	0	$0	0	$0
2023-12	10,000	$7,270	0	$0	0	$0
2023-09	10,000	$7,950	0	$0	0	$0
2023-08	0	$0	16,956	$19,235	0	$0
2022-06	46,400	$10,347	0	$0	0	$0
2020-06	107,547	$138,936	0	$0	0	$0
2019-11	33,379	$59,548	0	$0	0	$0
2019-08	15,000	$32,810	0	$0	0	$0
2019-06	5,000	$11,550	0	$0	0	$0
2019-03	19,000	$56,886	0	$0	0	$0
2019-02	20,609	$57,909	0	$0	0	$0
2018-12	18,610	$53,799	0	$0	0	$0
2018-11	41,700	$123,139	0	$0	0	$0
2018-10	0	$0	33,567	$167,835	0	$0
2018-09	0	$0	6,953	$31,288	0	$0
2018-08	57,300	$159,487	0	$0	0	$0
2018-06	5,000	$16,735	0	$0	0	$0
2018-05	5,000	$15,925	0	$0	0	$0
2017-11	35,000	$66,680	0	$0	0	$0
2017-10	0	$0	10,161	$53,751	37,500	$45,000

Table 3. Detailed insider trading at *Talphera, Inc.* (*TLPH*)
Trade Date	Insider Name	Trade Type	Shares	Price ($)	Value ($)
2026-02-12	Aslam Shakil (Chief Medical Officer)	Buy	35,000	.81	28,420
2026-02-12	Angotti Vincent J. (CHIEF EXECUTIVE OFFICER)	Buy	105,364	.81	85,555
2026-02-12	Asadorian Raffi (Chief Financial Officer)	Buy	45,000	.81	36,540
2026-02-12	Dasu Badri N (Chief Engineering Officer)	Buy	35,000	.81	28,420
2024-12-05	Angotti Vincent J. (CHIEF EXECUTIVE OFFICER)	Buy	5,000	.64	3,200
2024-12-02	Asadorian Raffi (Chief Financial Officer)	Sale	155	.77	118
2024-11-27	Angotti Vincent J. (CHIEF EXECUTIVE OFFICER)	Buy	5,000	.73	3,650
2024-08-30	Angotti Vincent J. (CHIEF EXECUTIVE OFFICER)	Buy	7,260	1.05	7,601
2024-06-14	Aslam Shakil (Chief Medical Officer)	Buy	5,000	1.07	5,355
2024-06-14	Angotti Vincent J. (CHIEF EXECUTIVE OFFICER)	Buy	1,304	1.08	1,404
2024-06-13	Aslam Shakil (Chief Medical Officer)	Buy	695	.98	681
2024-06-13	Angotti Vincent J. (CHIEF EXECUTIVE OFFICER)	Buy	4,570	.97	4,437
2024-06-12	Angotti Vincent J. (CHIEF EXECUTIVE OFFICER)	Buy	4,126	.97	4,014
2023-12-13	Angotti Vincent J. (Chief Executive Officer)	Buy	10,000	.73	7,270
2023-09-11	Angotti Vincent J. (Chief Executive Officer)	Buy	10,000	.80	7,950
2023-08-25	Palmer Pamela P (Chief Medical Officer)	Sale	7,442	1.09	8,104
2023-08-24	Palmer Pamela P (Chief Medical Officer)	Sale	9,514	1.17	11,131
2022-06-07	Angotti Vincent J. (Chief Executive Officer)	Buy	46,400	.22	10,347
2020-06-15	Angotti Vincent J. (Chief Executive Officer)	Buy	7,547	1.33	10,037
2020-06-15	Adams Adrian (Director)	Buy	100,000	1.29	128,899
2019-11-12	Edwards Mark G (Director)	Buy	25,000	1.78	44,575
2019-11-11	Angotti Vincent J. (Chief Executive Officer)	Buy	8,379	1.79	14,973
2019-08-26	Edwards Mark G (Director)	Buy	5,000	2.17	10,850
2019-08-23	Edwards Mark G (Director)	Buy	10,000	2.20	21,960
2019-06-05	Angotti Vincent J. (Chief Executive Officer)	Buy	5,000	2.31	11,550
2019-03-12	Edwards Mark G (Director)	Buy	19,000	2.99	56,886
2019-02-28	Angotti Vincent J. (Chief Executive Officer)	Buy	3,234	2.81	9,087
2019-02-28	Asadorian Raffi (Chief Financial Officer)	Buy	3,647	2.81	10,248
2019-02-28	Hamel Lawrence G (Chief Development Officer)	Buy	3,682	2.81	10,346
2019-02-28	Palmer Pamela P (Chief Medical Officer)	Buy	840	2.81	2,360
2019-02-28	Dasu Badri N (Chief Engineering Officer)	Buy	9,206	2.81	25,868
2018-12-14	Angotti Vincent J. (Chief Executive Officer)	Buy	3,610	2.78	10,024
2018-12-14	Asadorian Raffi (Chief Financial Officer)	Buy	5,000	2.78	13,885
2018-12-12	Angotti Vincent J. (Chief Executive Officer)	Buy	10,000	2.99	29,890
2018-11-19	Palmer Pamela P (Chief Medical Officer)	Buy	16,000	3.07	49,120
2018-11-15	Edwards Mark G (Director)	Buy	20,700	2.82	58,374
2018-11-13	Asadorian Raffi (Chief Financial Officer)	Buy	5,000	3.13	15,645
2018-10-15	Hamel Lawrence G (Chief Development Officer)	Sale	5,216	5.00	26,080
2018-10-15	Dasu Badri N (Chief Engineering Officer)	Sale	28,351	5.00	141,755
2018-09-24	Hamel Lawrence G (Chief Development Officer)	Sale	6,953	4.50	31,288
2018-08-07	Angotti Vincent J. (Chief Executive Officer)	Buy	10,000	2.90	28,950
2018-08-07	Edwards Mark G (Director)	Buy	5,300	2.84	15,062
2018-08-06	Asadorian Raffi (Chief Financial Officer)	Buy	5,000	2.75	13,725
2018-08-06	Palmer Pamela P (Chief Medical Officer)	Buy	37,000	2.75	101,750
2018-06-05	Edwards Mark G (Director)	Buy	4,700	3.35	15,745
2018-06-01	Edwards Mark G (Director)	Buy	300	3.30	990
2018-05-25	Asadorian Raffi (Chief Financial Officer)	Buy	5,000	3.19	15,925
2017-11-14	Edwards Mark G (Director)	Buy	30,000	1.90	56,970
2017-11-13	Asadorian Raffi (Chief Financial Officer)	Buy	5,000	1.94	9,710
2017-10-19	Dasu Badri N (Chief Engineering Officer)	Option Ex	37,500	1.20	45,000
2017-10-02	Hamel Lawrence G (Chief Development Officer)	Sale	10,161	5.29	53,751
2017-09-25	Hamel Lawrence G (Chief Development Officer)	Sale	13,827	.00	0
2017-09-11	Asadorian Raffi (Chief Financial Officer)	Buy	7,000	3.24	22,708
2017-08-24	Angotti Vincent J. (Chief Executive Officer)	Buy	15,000	3.00	45,000
2017-08-24	Edwards Mark G (Director)	Buy	4,800	3.02	14,520
2017-08-22	Palmer Pamela P (Chief Medical Officer)	Buy	10,000	2.95	29,490
2017-08-22	Edwards Mark G (Director)	Buy	200	2.90	580
2017-06-19	Edelman Joseph (10% Owner)	Sale	875,000	2.40	2,100,000
2016-09-29	Perceptive Life Sciences Master Fund Ltd	Sale	97,200	3.88	377,136
2016-09-28	Perceptive Life Sciences Master Fund Ltd	Sale	119,300	3.96	472,428
2016-09-15	Perceptive Life Sciences Master Fund Ltd	Sale	392,850	3.68	1,444,902
2016-05-13	Rosen Howard B (CEO)	Buy	10,206	3.26	33,271
2016-05-12	Edwards Mark G (Director)	Buy	5,000	3.05	15,250
2016-05-11	Edwards Mark G (Director)	Buy	5,000	3.15	15,750
2016-05-10	Edwards Mark G (Director)	Buy	5,000	3.25	16,250
2015-11-18	Perceptive Life Sciences Master Fund Ltd	Sale	42,300	5.35	226,135
2015-11-17	Perceptive Life Sciences Master Fund Ltd	Sale	133,900	5.36	717,436
2015-11-06	Perceptive Life Sciences Master Fund Ltd	Sale	17,100	4.47	76,368
2015-11-05	Perceptive Life Sciences Master Fund Ltd	Sale	75,000	4.62	346,275
2015-09-09	Perceptive Life Sciences Master Fund Ltd	Sale	310,000	4.18	1,294,869
2015-08-20	Palmer Pamela P (Chief Medical Officer)	Option Ex	29,000	2.56	74,240
2015-05-19	Rosen Howard B (Intermin CEO)	Buy	35,400	.00	0
2015-05-07	Edwards Mark G (Director)	Buy	40,000	3.13	125,120
2015-03-12	Palmer Pamela P (Chief Medical Officer)	Option Ex	25,000	1.32	33,000
2014-06-23	Afable Richard (Director)	Buy	1,000	10.30	10,300

Insider trading activities including stock purchases, stock sales, and option exercises of TLPH listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Talphera, Inc. (symbol TLPH, CIK number 1427925) see the Securities and Exchange Commission (SEC) website.

▪ Real-time Insider Trading

▪ Insider Officer Cluster Trading

▪ Top Officer Buys of the Week

▪ Top Officer Buys of the Month